Securities code: 002816 securities abbreviation: Shenzhen Hekeda Precision Cleaning Equipment Co.Ltd(002816) Announcement No.: 2022-011 Shenzhen Hekeda Precision Cleaning Equipment Co.Ltd(002816)
Announcement on the reply to the letter of concern of Shenzhen Stock Exchange
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The “attention letter to the listed company” (hereinafter referred to as the “attention letter to the listed company” No. 816} “issued by Shenzhen Stock Exchange on {0022}” on {2026) (hereinafter referred to as the “attention letter to the listed company” issued on {0026} “on {20226). According to the requirements of the letter of concern, the company now replies to the relevant information as follows:
The 2021 annual performance forecast (hereinafter referred to as the performance forecast) disclosed by your company on January 21, 2022 shows that the net profit attributable to the shareholders of the listed company in 2021 is 16 million yuan to 22 million yuan, turning losses into profits; The net profit after deducting non recurring profits and losses is a loss of 26 million yuan to 32 million yuan. The reason for the performance change is that the company’s operating income increased to a certain extent in 2021, the impairment loss accrued decreased, and the investment income generated from the sale of 100% equity of its subsidiary Suzhou Shenzhen Hekeda Precision Cleaning Equipment Co.Ltd(002816) ultrasonic equipment Co., Ltd. (hereinafter referred to as “Suzhou ultrasonic”). Among them, the investment income from the sale of Suzhou ultrasound equity belongs to non recurring profits and losses. It is preliminarily estimated that the impact on the net profit attributable to the shareholders of the listed company in 2021 is about 50 million yuan to 60 million yuan.
Our department is concerned about the above situation. Please verify and explain the following matters:
1. Your company achieved an operating revenue of 83.7629 million yuan in the first three quarters of 2021. Please explain whether your company still touches item (IV) of paragraph 1, article 5.1.1 of the stock listing rules (revised in 2022) in combination with the operating income and its deduction in 2021. If so, please make supplementary disclosure to the performance forecast and timely and fully disclose the risks.
[company reply]:
(1) The company’s operating income and deduction in 2021 are as follows:
Unit: 10000 yuan
Specific contract deduction in 2021
Operating income 20019.13
Contract classification and specific deduction in 2021
Deducting material sales and new servers in the current period
Less: business income unrelated to main business 1746.03 sales income, etc
Income without commercial substance 0
Deduct the business income and non profit irrelevant to the main business
The operating income after the income with commercial substance is 18273.10
Note: the above data has not been audited, and the final data deduction shall be subject to the audit results of the annual audit accountant.
(2) Item (IV) of paragraph 1 of article 5.1.1 of the stock listing rules (revised in 2022) stipulates as follows:
Article 5.1.1 where a listed company is expected to have one of the following circumstances in its annual operating performance and financial status, it shall make a notice within one month from the end of the accounting year: (IV) the lower of the net profit before and after deducting non recurring profits and losses is negative, and the operating income after deducting the business income irrelevant to the main business and the income without commercial substance is less than 100 million yuan;
The company’s operating income after deducting the business income irrelevant to the main business and the income without commercial substance is 183 million, which does not touch this rule.
2. In combination with the industry environment, business development and debt recovery, the year 2021 will be described in detail
The reason and rationality of the decrease of the impairment loss accrued compared with 2020, whether the accounting policy and determination basis of the impairment loss accrued in 2021 have changed significantly compared with 2020, if so, explain the specific reasons for the change, and on this basis, explain whether the impairment loss accrued in previous years is sufficient.
[company reply]:
The industry in which the company is located belongs to the non standardized customization industry, which is a supporting industry for industrial production. Its industry cycle is closely related to the operation status of downstream industries, technological innovation and fixed asset investment. Customers put forward cleaning requirements. The company manufactures relevant equipment according to customers’ requirements and is responsible for installation and maintenance. Enterprises in the industry adopt the professional supporting manufacturing business model of “customized production according to order”.
1. The asset impairment losses accrued in the two periods of the company are as follows:
Unit: 10000 yuan
Amount incurred in the current period (2021) amount incurred in the previous period (2020)
Inventory falling price loss -314.99 -1904.46
Impairment loss of contract assets -12.09
Total -327.09 -1904.46
Note: if there is any difference in the mantissa between the sum of some total numbers and each detailed number in this table, it is caused by rounding.
The amount of asset impairment loss accrued by the company in the current period decreased by 15.7737 million yuan compared with the previous period, which is mainly due to the decrease of 15.8947 million yuan in inventory falling price loss accrued in the current period compared with the previous period.
2. The company’s inventory falling price reserves at the end of two periods:
(1) Inventory depreciation reserves at the end of 2021:
Unit: 10000 yuan
Increase in current period decrease in current period
Project opening balance closing balance
Reversal of provision for others
Raw materials 455.46 33.10 422.36
In product 3553.22 314.99 443.45 123.58 3301.18
Total 4008.68 314.99 476.55 123.58 3723.54
Note: other decreases are the amount of inventory falling price reserves at the end of the period for the disposal of subsidiaries.
(2) Inventory depreciation reserves at the end of 2020:
Unit: 10000 yuan
Increase in current period decrease in current period
Project opening balance closing balance
Reversal of provision for others
Raw materials 455.46 455.46
Work in progress 2839.44 1449.00 735.22 3553.22
Total 2839.44 1904.46 735.22 4008.68
It can be seen from the above two tables that the company has made a large amount of impairment provision for products in process in 2020, resulting in a large difference in the amount of inventory falling price provision in the two periods. See point 3 “company inventory falling price provision policy” for the reasons and rationality of the provision.
3. The company’s inventory falling price reserve policy:
The net realizable value of the company’s inventory is determined by the estimated selling price of the inventory minus the estimated cost to be incurred at the time of completion, estimated selling expenses and relevant taxes.
When determining the net realizable value of inventories, it shall be based on the reliable evidence obtained, and consider the purpose of holding inventories, the impact of events after the balance sheet date and other factors.
(1) For inventories directly used for sale, in the normal process of production and operation, the net realizable value is determined by the amount of the estimated selling price of the inventory minus the estimated selling expenses and relevant taxes. For inventories held for the execution of sales contracts or labor contracts, the contract price shall be taken as the measurement basis of their net realizable value; If the quantity of inventory held is more than the quantity ordered in the sales contract, the net realizable value of the excess inventory is measured based on the general sales price. For materials used for sale, the market price shall be taken as the measurement basis of their net realizable value. (2) In the normal production and operation process, the net realizable value of the inventory of materials that need to be processed is determined by the estimated selling price of the finished products minus the estimated cost to be incurred at the time of completion, estimated selling expenses and relevant taxes.
The company conducts a comprehensive inventory of inventories on the balance sheet date. If it is found that the inventory cost is higher than its net realizable value, the inventory falling price reserves shall be withdrawn according to single item or category and included in the current profit and loss.
On the balance sheet date, if the factors affecting the previous write down of inventory value have disappeared, the amount written down shall be restored and reversed within the amount of inventory falling price reserves that have been accrued, and the reversed amount shall be included in the current profit and loss. In 2020, the company accrued 19.0446 million yuan of inventory falling price loss, including 4.5546 million yuan of raw materials and 14.49 million yuan of products in process, and hired Shanghai Zhonghua Asset Appraisal Co., Ltd. to issue the asset appraisal report with document No.: Huzhong pingbao Zi (2021) No. 0110. The reasons for withdrawal are as follows:
① The sales revenue of the company’s water treatment business and electroplating business has continued to decline in the past two years, and the turnover of some raw materials is slow. The company checked the raw materials and made an impairment provision of 4.5546 million yuan in accordance with the standards. ② The company mainly produces non-standard customized products, and the net realizable value is calculated according to the single product corresponding to the sales contract. Due to the business difficulties of some customers or changes in business strategy, there are major doubts about the possibility of continuing the execution of relevant contracts. The company has accrued an impairment provision of 14.49 million yuan in accordance with the standards.
In 2020, the company sorted out, checked and evaluated the products in process and raw materials with slow turnover involved in the execution of problematic orders, and made full provision for impairment according to the results of sorting, checking and evaluation. Therefore, the amount of inventory falling price loss accrued in 2020 was large. In 2021, the impairment provision of 3.4499 million yuan was accrued for relevant inventories according to the provisions of the standard, It does not involve the impairment of problem orders and raw materials with slow turnover, so the provision for impairment is greatly reduced.
To sum up, the accounting policies and determination basis for the provision of impairment losses in 2021 have not changed significantly compared with 2020, and the provision of impairment losses in previous years is sufficient.
3. In combination with the accounting standards for business enterprises, explain in detail the recognition basis that the company will no longer include Suzhou ultrasound in the scope of consolidated statements and the compliance and rationality of investment income recognition.
[company reply]:
1. According to Article 7 of the accounting standards for Business Enterprises No. 33 – consolidated financial statements (hereinafter referred to as the “No. 33 standard”), the consolidation scope of the consolidated financial statements shall be determined on the basis of control. Control means that the investor has control over the invested
